Comment on: Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 98, Issue 5, 2004, Pages 268-269

  Winstanley, Peter ^a   Molyneux, Malcolm ^b,c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTESUNATE; CHLORPROGUANIL PLUS DAPSONE; ISOQUINE; UNCLASSIFIED DRUG;

AFRICA; ANTIBIOTIC RESISTANCE; AUDIOMETRY; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG SYNTHESIS; FINANCIAL MANAGEMENT; HUMAN; MALARIA CONTROL; MALARIA FALCIPARUM; NOTE; OTOTOXICITY; POSTMARKETING SURVEILLANCE; REPRODUCIBILITY; REPRODUCTIVE TOXICITY;

ARTESUNATE;

EID: 3242702545     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2003.12.001     Document Type: Note

References (1)

1. WHO, 2003. Assessment of the Safety of Artemisinin Compounds in Pregnancy. World Health Organization, Geneva, WHO/CDS/MAL/2003.1094, WHO/RBM/TDR/Artemisinin/03.1. Available online at: http://rbm.who.int/cmc_upload/0/000/016/323/artemisinin_pregnancy.pdf